Boost therapy of hepatocellular carcinoma by amplifying vicious cycle between mitochondrial oxidative stress and endoplasmic reticulum stress via biodegradable ultrasmall nanoparticles and old drug

氧化应激 内质网 线粒体 化学 药品 癌症研究 肝细胞癌 细胞生物学 纳米颗粒 压力(语言学) 药理学 生物物理学 纳米技术 医学 材料科学 生物化学 生物 哲学 语言学
作者
Hao Zhang,Li Wang,Hanghang Liu,Yaobao Han,Qing Yin Zheng,Qi Xu,Bolin Bao,Wei Xing,Zhen Li
出处
期刊:Nano Today [Elsevier BV]
卷期号:46: 101601-101601 被引量:18
标识
DOI:10.1016/j.nantod.2022.101601
摘要

Despite advances in early diagnosis and treatment of hepatocellular carcinoma (HCC), HCC shows a very high mortality and development of innovative drugs and treatment methods are highly desirable. Herein, we report an innovative therapy of HCC through the formation and amplification of vicious cycle between mitochondrial oxidative stress and ER stress by joint use of biodegradable ultrasmall Cu 2- x Se nanoparticles (CS NPs) and alcohol-abuse drug disulfiram (DSF). The CS NPs can alleviate the tumor hypoxia and generate reactive oxygen species (ROS) through their Fenton-like reaction with endogenous H 2 O 2 in tumor. Their released copper ions can react with DSF to in situ form active drug CuET to significantly suppress the growth of HCC and exhibit excellent anti-tumor effect. We reveal the novel anti-tumor mechanism of the formed CuET complex, which can immobilize nuclear protein localization protein 4 (NPL4) to inhibit the proteasome system to induce endoplasmic reticulum (ER) stress and increase the burden of Ca 2+ ions in mitochondria, leading to mitochondrial oxidative stress and the burst of ROS. The mitochondrial oxidative stress produces less ATP to induce the occurrence of autophagy, and the generated ROS further strengthens the ER stress. The formation of such vicious cycle between mitochondrial oxidative stress and ER stress significantly enhances the severe apoptosis of tumor cells and notable decrease in tumor size, which has been demonstrated in both subcutaneous and orthotopic HCC models. Our work provides insights into repurposing of metabolic nanoparticles and old drugs for new applications, demonstrates the great potential of this strategy in anti-tumor therapy. • Joint use of Cu2-xSe NPs and disulfiram can suppress HCC growth due to the in situ formation of anti-tumor drug CuET. • The CuET can cause and amplify a vicious cycle between ER stress and mitochondrial oxidative stress. • The ER stress increases the burden of Ca2+ in mitochondria, leading to mitochondrial oxidative stress and the burst of ROS. • The mitochondrial damage produces less ATP to induce autophagy, and the burst of ROS further strengthens the ER stress.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
喔喔发布了新的文献求助10
2秒前
领导范儿应助ouhu采纳,获得10
5秒前
penghui完成签到,获得积分10
6秒前
小元发布了新的文献求助10
7秒前
7秒前
彭于晏应助slx采纳,获得10
8秒前
8秒前
Hola发布了新的文献求助10
8秒前
9秒前
结实擎苍发布了新的文献求助10
11秒前
11秒前
丸橙发布了新的文献求助10
12秒前
zys完成签到 ,获得积分10
12秒前
13秒前
满心欢喜完成签到,获得积分10
14秒前
15秒前
科研通AI5应助五本笔记采纳,获得10
15秒前
18秒前
满心欢喜发布了新的文献求助10
19秒前
yammy发布了新的文献求助10
19秒前
大模型应助微笑天使采纳,获得10
20秒前
MoNesy完成签到,获得积分10
22秒前
22秒前
脑洞疼应助xzxz采纳,获得10
22秒前
sxy0604发布了新的文献求助10
24秒前
26秒前
26秒前
yml发布了新的文献求助10
27秒前
hdn发布了新的文献求助10
29秒前
29秒前
30秒前
taku发布了新的文献求助10
31秒前
烟花应助yammy采纳,获得10
35秒前
无花果应助zz采纳,获得10
36秒前
传奇3应助sxy0604采纳,获得10
39秒前
搞怪的访旋完成签到,获得积分10
40秒前
Orange应助ichigo采纳,获得10
40秒前
善学以致用应助慕容飞凤采纳,获得10
40秒前
40秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
The First Nuclear Era: The Life and Times of a Technological Fixer 500
岡本唐貴自伝的回想画集 500
Distinct Aggregation Behaviors and Rheological Responses of Two Terminally Functionalized Polyisoprenes with Different Quadruple Hydrogen Bonding Motifs 450
Ciprofol versus propofol for adult sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3670761
求助须知:如何正确求助?哪些是违规求助? 3227655
关于积分的说明 9776657
捐赠科研通 2937838
什么是DOI,文献DOI怎么找? 1609653
邀请新用户注册赠送积分活动 760441
科研通“疑难数据库(出版商)”最低求助积分说明 735894